Oversea-Chinese Banking Corporation Limited (OCBC Bank) is one of the largest financial institutions in the combined Singapore-Malaysia market in terms of assets. The company recorded revenues of SGD4,281 million (approximately $2,843 million) for the financial year ended December 2007.
Scope of this report
*
Contains corporate strategy, value chain presence and SWOT Analysis
*
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
*
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Research and analysis highlights
OCBC Bank has a dominant presence in both the consumer and business banking segments in Singapore and Malaysia. Its insurance subsidiary, Great Eastern Holdings, is the largest insurance group in Singapore and Malaysia in terms of assets and market share.
The bank’s core banking (deposits and loans) operations have been exhibiting decent growth for the last five years ending 2007. Deposits registered a CAGR of 13.52% over 2003 to touch $58.96 billion in 2007. Similarly, loans registered a CAGR of 15.6% over 2003 to touch $47.36 billion in 2007.
OCBC Bank’s NPL (non performing loans) have been continuously declining since 2003. The bank’s NPL fell from $2,546 million in 2003 to $899 million in 2007. In 2008, OCBC Bank reported a 4% fall in net profit to SGD622 million for the first quarter, primarily due to its exposure to US sub-prime mortgage assets.
Key reasons to read this report
*
Access all the important information and analysis on the company in a single report
*
Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
*
Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=81978&rt=Premium-Company-Profile-Oversea-Chinese-Banking-Corporation-Limited.html
Or
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Forecast Insight: Parkinson’s Disease - Market upgrade following evidence of disease slowing with Azilect PDF Format
May 3rd, 2010
Stimulated by evidence of disease slowing with Teva/Lundbeck’s Azilect (rasagiline), and successful reformulation of leading dopamine agonists, the Parkinson’s disease market value is set to grow by an compound annual growth rate (CAGR) of 10% over the next 5 years (20072013), peaking at $3.1 billion in 2013.
Scope of this report
*
This report gives a strategic analysis of the likely impact that recent events will have on the future Parkinson’s disease market
*
Includes Parkinson’s disease-specific sales forecasts for the key brands and pipeline agents in the seven major markets to 2017
*
Provides a global market snapshot by including Parkinson’s disease-specific sales analysis for leading brands outside the seven major markets
*
Key conclusions are supported by key opinion leader comment
Research and analysis highlights
It has upgraded its forecasts of Teva/Lundbeck’s Azilect (rasagiline) following clinical evidence of disease slowing. Over the next 5 years Azilect is expected to become a standard first-line therapy, with sales peaking in 2013, making it the market leading Parkinson’s disease drug at this time.
GlaxoSmithKline’s Requip XL (ropinirole extended-release) is set to become the market leading dopamine agonist in 2009. The convenience of once-daily dosing, supported by the theoretical clinical advantage of smoother dopamine receptor agonism, will drive switching from the parent compound and Boehringer Ingelheim’s Mirapex (pramipexole).
It has downgraded its sales forecasts of UCB’s Neupro (rotigotine patch) as problems with crystallization of the active ingredient have led to supply issues at a critical phase in its lifecycle. Prescribers are now likely to switch to Requip XL, which arrived on the market at just the right time to take advantage of UCB’s misfortune.
Key reasons to read this report
*
Understand the impact of recent and anticipated events on the Parkinson’s disease market during the forecast period 2008 to 2017
*
Quantify the current size of the seven major markets and the trends in the rest of the world
*
Assess the impact of events, such as patent expiries and new product launches, on the Parkinson’s disease-specific sales of key brands
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=83044&rt=Forecast-Insight-Parkinsons-Disease-Market-upgrade-following-evidence-of-disease-slowing-with-Azilect.html
Or
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
This report on B_E_E forms part of It’s case studies series, which explores business practices across a variety of disciplines and business sectors. It highlights how it has been successful in the home cleaning market in New Zealand by producing true green products.
Key reasons to read this report
*
Gain insight into the methods used by important industry players to give them a competitive edge
*
Identify specific areas for operational improvements
*
Capitalize on the knowledge of experienced companies when entering a new niche or market
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=82937&rt=B_E_E-case-study-creating-an-ethical-and-profitable-cleaning-brand.html
Or
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Seeking Low Latency in Financial Markets
May 3rd, 2010
With the number of trading venues proliferating and automation growing in certain asset classes, the capital markets’ need for ultra-low latency, both in market data and trades, is growing.
Scope of this report
* Financial markets, particularly equities, options and derivatives, but also increasingly FX
* Networking, messaging, chip technology
Research and analysis highlights
Low-latency infrastructure for the financial markets is a fast-moving space that shows no sign of slowing down in the face of the greater crisis in the global banking and financial services industry.
Key reasons to read this report
* Gain an insight into how vendors are moving to meet the ever greater demands for low latency in the financial market
* See how some of the larger vendors are seeking to get into a space which has hitherto been dominated by small start-ups
For more information kindly visit http://www.bharatbook.com/detail.asp?id=84082&rt=Seeking-Low-Latency-in-Financial-Markets.html
Or
Contact us at
Bharat Book Bureau ÂÂÂ
Tel: +91 22 27578668   ÂÂÂ
Fax: +91 22 27579131
Email: info@bharatbook.com  ÂÂÂ
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Market Competitive Intensity (MCI) Pennsylvania
May 2nd, 2010
This series of market profiles covers 5 key markets in North America. Each profile provides insight into market structures, regulatory environments, supply and demand balances, assets, market concentration and wholesale sources of energy.
Scope of this report
*
Detailed overviews of energy market dynamics, players and trends.
*
Detailed insight into market fundamentals, infrastructure, national and regional legislation and supply and demand conditions.
*
Understanding of the competitive environment in each market.
Research and analysis highlights
Each profile offers a supply and demand balance showing a breakdown of both supply sources and consumption by end use sector.
Subsequent analysis provides a deeper analysis of supply and demand dynamics by looking at factors such as indigenous production trends, trade flows and current and historical sectoral demand trends.
The profiles also include a detailed analysis of each market’s regulatory structure. This provides an examination of key governmental, legal and political influences on the energy sector. Each profile also contains an overview of energy assets and infrastructure at various stages of the value chain.
Key reasons to read this report
*
Obtain up-to-date, relevant and standardised information on North American energy market dynamics and markets from a single source.
*
Gain a logical framework to monitor market development trends, identify opportunities and plan strategies.
*
Save time tracking multiple information sources.
For more information kindly Visit us http://www.bharatbook.com/detail.asp?id=81095&rt=Market-Competitive-Intensity-MCIPennsylvania.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Competitive Dynamics in the UK Mortgage Market
April 29th, 2010
HTML clipboard
2007 proved to be one of the most challenging years in recent times for UK mortgage lenders, as the later part of 2007 saw the mortgage sector being marred by liquidity issues. While mortgage lending reached record levels in 2007, it is expected to fall significantly in 2008. Who will be the winners and losers of the most difficult year of the UK mortgage market in the last decade?
-
Provides top ten competitor market shares in terms of gross advances and balances outstanding.
-
Provides market share over the period 2001 to 2007.
-
Discusses the key competitive changes in the market over the last twelve months.
The biggest UK mortgage lender has steadily been losing share over the last seven years. The lender held nearly a quarter of total gross lending in 2001. This figure was down to 19.9% by 2007.
Most major lenders attributed their 2007 good results to a mixture of competitive pricing and good retention strategies.
With fewer products available on the market and consumer demand remaining strong, the dynamics are changing. Lenders are currently in a position where they can charge higher prices without this affecting demand.
-
Gain insight on which major lenders are performing well in a highly competitive market.
-
Learn how the market is changing and evaluate any opportunities for your business arising from these changes.
-
Understand how lenders are responding in a market where liquidity is an issue.
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=78534&rt=Competitive-Dynamics-in-the-UK-Mortgage-Market.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Premium Company Profile: Mighty River Power Limited
April 29th, 2010
HTML clipboard
Mighty River Power plans to pursue the development of related business activities which add value to the core business and are consistent with its business plan and the prudent management of its business risks.
-
Contains corporate strategy, value chain presence and SWOT Analysis
-
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
-
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Mighty River Power is engaged in generation and distribution of electricity. The company is also involved in distribution of gas, and providing meters and meter reading services to residential and commercial customers through its metering business.
Mighty River Power recorded operating revenues of NZD768.9 million (approximately $527.5 million) during the fiscal year ended June 2007, a decrease of 23.8% compared with 2006. The decrease in operating revenue was due to lower electricity spot prices during the second half of fiscal year 2007.
Mighty River Power’s generation assets collectively account for up to 22% of New Zealand’s peak energy demand. The company operates a diverse generation portfolio and more than 20% of its energy production is non-hydro.
-
Access all the important information and analysis on the company in a single report
-
Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
-
Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
Table of Contents
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=78018&rt=Premium-Company-Profile-Mighty-River-Power-Limited.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Premium Company Scorecard: First Energy
April 29th, 2010
HTML clipboard
The 4 pillars each provide an insight into the dynamics of the selected company. The performance pillar combines 5 financial metrics to measure business performance; the Scale pillar combines financial and operational metrics; the Growth pillar measures the rate of growth of financial and energy resources whilst the Exposure pillar combines both operational and financial measurements of risk.
-
A thorough review of the key operational and financial metrics that drive utility performance.
-
A comparison and ranking of key metrics across North America’s leading utilities.
Companies are scored out of 5, and are ranked out of 35 on each of the metrics
Companies are then scored out of 25 and ranked out of 35 for an overall “Performance” score, reflecting the weighting of each metric
-
See where players rank in It’s North American utility scorecard
-
Gain a comprehensive assessment of positioning across North America
-
Acquire a wealth of company data from retail volumes to structural hedge positions
For more information kindly visit us    http://www.bharatbook.com/detail.asp?id=77920&rt=Premium-Company-Scorecard-First-Energy.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Premium Company Scorecard: Edison International
April 29th, 2010
HTML clipboard
The 4 pillars each provide an insight into the dynamics of the selected company. The performance pillar combines 5 financial metrics to measure business performance; the Scale pillar combines financial and operational metrics; the Growth pillar measures the rate of growth of financial and energy resources whilst the Exposure pillar combines both operational and financial measurements of risk.
-
A thorough review of the key operational and financial metrics that drive utility performance.
-
A comparison and ranking of key metrics across North America’s leading utilities.
Companies are scored out of 5, and are ranked out of 35 on each of the metrics
Companies are then scored out of 25 and ranked out of 35 for an overall “Performance” score, reflecting the weighting of each metric
-
See where players rank in It’s North American utility scorecard
-
Gain a comprehensive assessment of positioning across North America
-
Acquire a wealth of company data from retail volumes to structural hedge positions
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=77858&rt=Premium-Company-Scorecard-Edison-International.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Geron Corporation: Premium Company Profile
April 27th, 2010
HTML clipboard
Geron, a biotechnology company, specializes in developing telomerase targeted therapies for cancer and chronic degenerative diseases and human embryonic stem cell-based therapeutics. The company develops anti-cancer therapies based on telomerase inhibitors, telomerase therapeutic vaccines, and through its licensee, telomerase-based oncolytic viruses.
-
Contains corporate strategy, value chain presence and SWOT Analysis
-
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
-
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Geron’s clinical portfolio includes GRN163L and GRN163L, currently being studied in Phase I/ II trials for the treatment of various cancer indications.
Geron’s revenues increased at a CAGR of 27% during 2002-2006, from $1 million to $3 million. This increase was mainly due to the increase in royalties, license fees, contract and collaborative revenues along with royalties from the product sales of telomerase detection and telomere measurement kits.
Geron’s revenues are forecast to grow at a CAGR of 54% from $3 million in 2006 to $18 million in 2010, mainly due to the expected increase in milestone payments from Merck.
-
Access all the important information and analysis on the company in a single report
-
Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
-
Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
For more information kindly visit us http://www.bharatbook.com/detail.asp?id=76504&rt=Geron-Corporation-Premium-Company-Profile.html
Or
Contact us at
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook